Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...